DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Fezolamine
Fezolamine
References
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
Appendix E-3: Complete Search Strategy
(73) Assignee: Epicept Corporation, Englewood E. E. E. N. "...O's E Cliffs, NJ (US) 6,245,781 B1 6/2001 Upadhyay Et Al
Supplemental Digital Content 1 Search Strategy (First Conducted on January 17, 2014; Second Retrieval on November 5, 2014)
United States Patent (10) Patent N0.: US 6,951,860 B2 Mehanna Et A1
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Use of Isoindoles for the Treatment of Neurobehavioral Disorders
(12) Patent Application Publication (10) Pub. No.: US 2005/0096349 A1 Shapira Et Al
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
(12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
Pharmaabkommen A1 E
Customs Tariff - Schedule Xxi - 1
Combination of a Sedative and a Neurotransmitter Modulator, and Methods for Improving Sleep Quality and Treating Depression
Harmonized Tariff Schedule of the United States (2005) Annotated for Statistical Reporting Purposes
Improved Etifoxine
Amaroju Suresh -2012PHXF0530H.Pdf
Top View
Harmonized Tariff Schedule of the United States (2006) (Rev
Antidepressant Treatment of Depression in Schizophrenia: a Systematic Review and Meta-Analysis
Table [1]: Definition of Reported Outcomes Study Outcome
Pharmaceutical Appendix to the Tariff Schedule 2
Reboxetine for Treating Migraine Headaches Reboxetin Zur Behandlung Von Migränekopfschmerzen Reboxétine Pour Traiter Les Migraines
Synthesis of New Dihydropyrazoles of Designed Curcumin Analogues
(12) United States Patent (10) Patent No.: US 8,802,596 B2 Rogers Et Al
Wo 2007/005962 A2
Pharmaceuticals Appendix
(12) United States Patent (10) Patent No.: US 8,697,361 B2 Johnson (45) Date of Patent: Apr
United States Patent (19) 11 Patent Number: 5,922,341 Smith Et Al
Schedule Clxxiii - European Union
(S,S) Reboxetine for Treating Attention Deficit Disorder